Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03895164
Other study ID # LPBadutaSM
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date December 19, 2018
Est. completion date December 31, 2019

Study information

Verified date March 2019
Source SEAMEO Regional Centre for Food and Nutrition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Stunting and anemia amongst under-two children are attributable to poor nutrient intakes. The study evaluates the effectiveness of nutrition education on local specific food-based complementary feeding recommendation (CFR) to improve dietary patterns and nutritional intakes, as well as reduce stunting and anemia among under-two children.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 926
Est. completion date December 31, 2019
Est. primary completion date October 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 11 Months
Eligibility Inclusion Criteria:

- 6-11 months old at baseline

- living in selected area during the study

- apparently healthy

- willing to take part in the study and taken venous blood sample by getting signed consent from parents

Exclusion Criteria:

- the child does not present during venous blood sample collection

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enhanced NE
Standard nutrition education package from primary health care enhanced with local specific food-based complementary feeding recommendation
Standard NE
Standard nutrition education package from primary health care

Locations

Country Name City State
Indonesia Malang District Health Office Malang West Java
Indonesia Sambas District Health Office Sambas West Borneo

Sponsors (7)

Lead Sponsor Collaborator
SEAMEO Regional Centre for Food and Nutrition Health Polytechnic of Malang, Health Polytechnic of Pontianak, Indonesia University, Malang District Health Office, Ministry of Health Republic of Indonesia, Sambas District Health Office

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in anthropometric measurements to measure the change in length measured by using WHO growth standard length-for-Age (Z-Score) before and after intervention period. At baseline before intervention (week 0), at midpoint of intervention (week 12), at endpoint after intervention (week 24)
Primary Change in hemoglobin status to measure the change in hemoglobin (g/L) before and after intervention At baseline before intervention (week 0), at endpoint after intervention (week 24)
Primary Change in iron status to measure the change in serum ferritin (microgram/L) before and after intervention At baseline before intervention (week 0), at endpoint after intervention (week 24)
Primary Change in zinc status to measure the change in serum zinc (mg/L) before and after intervention At baseline before intervention (week 0), at endpoint after intervention (week 24)
Secondary Change in dietary patterns Dietary patterns will be measured by using Dietary Diversity Score At baseline before intervention (week 0), at midpoint of intervention (week 12), at endpoint after intervention (week 24)
Secondary Change in iron intake iron intake (mg/day) At baseline before intervention (week 0), at midpoint of intervention (week 12), at endpoint after intervention (week 24)
Secondary Change in zinc intake zinc intake (mg/day) At baseline before intervention (week 0), at midpoint of intervention (week 12), at endpoint after intervention (week 24)
Secondary Change in calcium intake calcium intake (mg/day) At baseline before intervention (week 0), at midpoint of intervention (week 12), at endpoint after intervention (week 24)
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01432717 - Study of ACE-536 in Healthy Postmenopausal Women Phase 1
Completed NCT01458028 - Age and Gender Effects on the Pharmacokinetics of BAY85-3934 Phase 1